pharmaphorum2y
Bayer bails on $670m CAR-T partnership with Atara
In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a patient death. Now, its partner Bayer has backed out of a partnership covering two ...
Yahoo Finance7d
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) high institutional ownership speaks for itself as stock continues to impress, up 27% over last week
A look at the shareholders of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 48% ...